Charles River Laboratories International (CRL) Tax Rate (2009 - 2026)
Charles River Laboratories International (CRL) posted Tax Rate of 101.43% for Q2 2026, up 100.59% on a QoQ basis from 50.56% in Q1 2026, and up 7521.0% year-over-year from 1.33% in Q2 2025.
Analysis
Charles River Laboratories International (CRL) Tax Rate (2009 - 2026) Analysis & Trends
Charles River Laboratories International has reported Tax Rate for 18 years, with the latest figure at 101.43% in Q2 2026.
- On a quarterly basis, Tax Rate rose 7521.0% year-over-year to 101.43% in Q2 2026; TTM through Jun 2026 was 28.65%, a 22874.0% increase from a year earlier, with the FY2025 full-year figure at 42.87%, down 11571.0% from the prior year.
- Tax Rate was 101.43% for Q2 2026 at Charles River Laboratories International, up from 50.56% in the prior quarter.
- The five-year high for Tax Rate was 101.43% in Q2 2026, with the low at 1.4% in Q4 2024.
- Average Tax Rate over 5 years is 26.37%, with a median of 22.75% recorded in 2023.
- The sharpest annual moves came in 2023 and 2026: Tax Rate tumbled 1332 bps in 2023, then surged 7521 bps in 2026.
- Over 5 years, Tax Rate stood at 22.79% in 2022, then plunged by 58 bps to 9.46% in 2023, then plunged by 85 bps to 1.4% in 2024, then surged by 331 bps to 6.06% in 2025, then surged by 1575 bps to 101.43% in 2026.
- The last three Tax Rate figures came in at 101.43% (Q2 2026), 50.56% (Q1 2026), and 6.06% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 19.93% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 19.98% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -21.28% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 101.43% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -1,000.00% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -0.22% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -2.65% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 2.58% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -0.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 101.43% |
| Mar 28, 2026 | 50.56% |
| Dec 27, 2025 | 6.06% |
| Sep 27, 2025 | 36.29% |
| Jun 28, 2025 | 26.22% |
| Mar 29, 2025 | 28.07% |
| Dec 28, 2024 | 1.40% |
| Sep 28, 2024 | 22.96% |
| Jun 29, 2024 | 21.22% |
| Mar 30, 2024 | 24.77% |
| Dec 30, 2023 | 9.46% |
| Sep 30, 2023 | 22.02% |
| Jul 1, 2023 | 22.71% |
| Apr 1, 2023 | 20.67% |
| Dec 31, 2022 | 22.79% |
| Sep 24, 2022 | 20.71% |
| Jun 25, 2022 | 23.21% |
| Mar 26, 2022 | 14.09% |
| Dec 25, 2021 | 14.55% |
| Sep 25, 2021 | 14.69% |